Novartis Ag (NVS) Change in Acquisitions & Divestments (2017 - 2026)

Novartis Ag has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $87.0 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 190.0% year-over-year to $87.0 million; the TTM figure through Jun 2026 stood at $1.3 billion (down 67.95% YoY), while the FY2025 annual figure was $2.0 billion, down 28.28% from the prior year.
• Change in Acquisitions & Divestments came in at $87.0 million for Q2 2026 at Novartis Ag, down from $1.1 billion in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $15.2 billion in Q1 2022 to a low of $3.0 million in Q2 2023.
• Average Change in Acquisitions & Divestments over 5 years is $3.2 billion, with a median of $721.0 million recorded in 2024.
• Year-over-year, Change in Acquisitions & Divestments jumped 56422.73% in 2022 and plunged 99.86% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $9.7 billion in 2022, then plunged by 99.67% to $32.0 million in 2023, then surged by 2825.0% to $936.0 million in 2024, then slumped by 94.87% to $48.0 million in 2025, then surged by 81.25% to $87.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $87.0 million in Q2 2026, $1.1 billion in Q1 2026, and $48.0 million in Q4 2025.